Related by context. All words. (Click for frequent words.) 73 MDRD 67 generalized estimating 66 MDRD equation 66 HOMA IR 64 glomerular filtration rate 62 multivariate Cox 61 Prognostic 61 logistic regression analysis 61 dyssynchrony 61 nonparametric 61 Brief Psychiatric 61 Glomerular filtration rate 60 intact parathyroid hormone 60 TIMP 1 60 covariance 60 Rating Scale BPRS 60 univariate 60 Bonferroni correction 59 glomerular filtration 59 Endothelial dysfunction 59 Echocardiographic 59 Montgomery Åsberg Depression 59 residual confounding 59 interobserver reliability 59 κ 59 Main Outcome Measures 59 Cystatin C 59 left ventricular diastolic 59 Negative Syndrome 58 multivariable analysis 58 intraobserver 58 prospectively stratified 58 intraventricular 58 Prognostic Value 58 Congenital Heart Surgery 58 Tasigna prolongs 58 Pearson correlation coefficients 58 ADAS Cog 58 cognitive affective 58 Scale PANSS 58 Alzheimer Disease Assessment 58 confidence intervals CIs 58 Clinical Outcome 58 obstructive CAD 58 interobserver agreement 58 CrCl 58 semiquantitative 58 PCWP 58 ADAS cog 58 Main Outcome Measure 58 myocardial viability 58 interobserver 58 haemodynamic 58 SGRQ 58 Dysregulation 57 Univariate 57 metabolite concentrations 57 multiple linear regression 57 HAQ DI 57 plasma lipid 57 Montgomery Asberg Depression 57 kidney allograft 57 somatostatin analog 57 secondary efficacy endpoint 57 K ras mutations 57 plasma creatinine 57 Descriptive statistics 57 Prostate Cancer Recurrence 57 euthymic patients 57 Bioavailability 57 primary aldosteronism 57 transcranial Doppler ultrasound 57 leukocyte counts 57 Ischemic 57 Creatinine 57 Partial Response 57 DAS# remission 57 echocardiographic parameters 57 meta analytic 57 Ocular Surface Disease 57 Chronic Illness Therapy 57 HER2 expression 57 thyroglobulin 57 hematological parameters 57 hyperinsulinemic euglycemic clamp 57 univariate analysis 57 corneal astigmatism 57 covariate 57 lactate dehydrogenase LDH 57 isoenzyme 57 Incretin 57 bivariate 57 regression coefficient 57 Index CDAI 57 nitrotyrosine 57 morphometric 57 lactate dehydrogenase 57 apolipoproteins 57 eNO 57 baseline LDH 56 NGAL 56 ADCS CGIC 56 postoperative morbidity 56 Kaplan Meier 56 gadolinium enhanced 56 Kaplan Meier analysis 56 binary logistic regression 56 Pearson correlation coefficient 56 multivariable Cox 56 Cystic Fibrosis Questionnaire Revised 56 Visual Analogue Scale VAS 56 coronary stenosis 56 Histological 56 transient elastography 56 Mutational 56 Risk Stratification 56 PITX2 methylation 56 electroencephalographic 56 STRIDE PD 56 interrater reliability 56 apolipoprotein B 56 Endocrine Therapy 56 Cardiotoxicity 56 Scale cognitive subscale 56 SSc 56 VKORC1 56 % Confidence Interval 56 -#.# ± [002] 56 Severity MSCS score 56 etiologic 56 LV dysfunction 56 gene polymorphisms 56 Contrast Enhanced 56 EuroSCORE 56 leukocyte count 56 Hyperlipidemia 56 bone scintigraphy 56 conditional logistic regression 56 Multivariate 56 multivariable adjusted 56 CORE OM 56 LV ejection fraction 56 hematopoietic cancers 56 electrophysiologic 56 liver histology 56 lumbar spine BMD 56 Subgroup analysis 56 creatinine clearance 56 pharmacodynamic parameters 56 Treatment Outcome 56 iPTH 56 arteriolar 56 factorial 56 Virologic Response 56 HOXB# 56 logistic regression 56 Haptoglobin 56 hemoglobin Hb 56 Histologic 56 Hypothalamic 56 ultrasonographic 56 PANSS 56 MADRS score 56 Alternative splicing 56 Non Responders 56 autoregulation 56 Amino acid 56 antitrypsin 56 Bonferroni 56 Annexin V 56 CC genotype 56 -#.# mg dL [001] 56 clinicopathological 56 IL#B 56 FDG uptake 56 Alkaline Phosphatase 56 Arrhythmogenic 56 haematologic 56 ANOVA 56 DAS# CRP 56 Score TOS 56 Novel Inhibitor 56 p tau 56 tricuspid regurgitation 55 LDL HDL 55 multivariate logistic regression 55 NPM1 mutation 55 Mean Symptom Complex 55 Quantitation 55 histopathologic 55 stoichiometry 55 KRAS mutation status 55 See CLINICAL PHARMACOLOGY 55 Repeatability 55 Cardiac Troponin 55 immunohistochemical 55 Myocardial Perfusion 55 immunoblotting 55 multiple logistic regression 55 methylenetetrahydrofolate reductase 55 pulsatility 55 Heritability 55 cTnI 55 periprocedural 55 serum triglycerides 55 preoperative PSA 55 cystatin C 55 p# activation 55 glycaemia 55 EQ 5D 55 Univariate analysis 55 obstructive coronary artery 55 #ß 55 Prognostic significance 55 Kaplan Meier method 55 insulin resistance HOMA IR 55 Eur Urol 55 confounder 55 pairwise comparisons 55 Interrater reliability 55 J Clin 55 Pain Intensity 55 AST ALT 55 NIHSS score 55 PANSS Positive 55 Cholinesterase Inhibitors 55 Charlson comorbidity index 55 bronchoalveolar lavage 55 HLA DR4 55 arterial oxygen saturation 55 tryptophan depletion 55 serum phosphate 55 ABL1 55 Wilcoxon rank sum 55 Am J Cardiol 55 Reproducibility 55 postprocedure 55 Cardiorespiratory fitness 55 logistic regression analyzes 55 BENICAR HCT 55 myocardial perfusion 55 Peripheral Arterial 55 LOCF 55 PTPN# 55 ^ sup #m 55 Excretion 55 clinico pathological 55 TUNEL 55 Angiotensin converting enzyme 55 CTEPH 55 Homeostasis 55 CR nPR 55 urothelial 55 fractional shortening 55 Tyrosine Kinase Inhibitor 55 amisulpride 55 CHADS2 55 compulsive hoarding syndrome 55 chemosensitivity 55 atheroma volume 55 neurophysiologic 55 APACHE II 55 Poisson regression 55 #Gy 55 preoperative diagnosis 55 SCr 55 immunohistochemical analysis 55 Myocardial 55 FDG PET imaging 55 RQ PCR 55 Young modulus 55 Wechsler Memory 55 albumin excretion rate 55 multivariate analyzes 55 mitral annular 55 creatinine ratio 55 pulmonary arterial 55 malabsorptive 55 Epithelial Cell 55 intraabdominal 55 Pioglitazone 55 Pulsatile 55 D Dimer 55 Score DAS 55 -#.# log# 55 ANCOVA 54 liver metastasis 54 MMSE score 54 heterozygotes 54 Genotypic 54 Protein Structures 54 immunostaining 54 prospectively defined 54 Eq. 54 premorbid 54 Thrombolysis 54 serum creatinine 54 Postoperative 54 Pharmacokinetic parameters 54 triiodothyronine 54 NYHA functional class 54 Cardiopulmonary bypass 54 renal artery stenosis 54 perioperative complications 54 logistic regression models 54 femoral neck fracture 54 visceral adiposity 54 triglyceride TG 54 NMIBC 54 J Am Coll 54 Pharmacodynamic 54 convergent validity 54 mRNA expression 54 Symptom severity 54 TURBT 54 Health Assessment Questionnaire 54 abacavir lamivudine 54 Secondary endpoints included 54 ASIA Impairment 54 statistical significance p 54 PCR RFLP 54 radiographic findings 54 reactive hyperemia 54 Kaplan Meier survival 54 APOE genotype 54 voxel 54 Lipoprotein 54 inducible nitric oxide synthase 54 ADCS ADL 54 Neurocognitive 54 CK MB 54 Scale EDSS 54 nondiabetic patients 54 TNFalpha 54 Diabetic Foot Ulcer 54 Primary endpoints 54 Estrogen Receptor 54 TRUS 54 transabdominal 54 coagulopathy 54 chi squared 54 gastric carcinoma 54 inhibin B 54 stratifying patients 54 interleukin IL -# 54 Histopathologic 54 nodal metastases 54 #F FDG PET 54 serum triglyceride 54 tissue oxygenation 54 ABCB1 54 prespecified secondary 54 ligand induced 54 logistic regression model 54 prostate carcinoma 54 aspartate aminotransferase AST 54 sensitivity specificity 54 carcinoembryonic antigen 54 Neuropsychiatric Inventory NPI 54 Stent thrombosis 54 baroreceptor 54 bronchial hyperresponsiveness 54 multiplicative 54 Hemoglobin A1c 54 Hypertriglyceridemia 54 ROC curves 54 selective cerebral perfusion 54 ASCUS 54 Glomerular Filtration Rate 54 Immunohistochemistry 54 MyoCell SDF 1 54 UPDRS 54 PSADT 54 Pischon 54 serum lipid 54 Nephrol 54 WAIS III 54 Inosine 54 Logistic regression 54 ± SEM 54 left ventricular LV 54 PANSS total 54 FDG-PET/CT 54 Sensitivity specificity 54 morphologic characteristics 54 clinically meaningful reductions 54 alanine aminotransferase 54 Phenotypic 54 differential gene expression 54 ACI TIPI 54 parenchymal 54 pT2 54 steroidogenic 54 hematologic parameters 54 risk reducing salpingo 54 plasma proteome 54 Renal Insufficiency 54 creatine kinase MB 54 epistasis 54 Left Ventricular 54 tricalcium phosphate 54 lymph node metastasis 54 Coronary Artery Bypass Surgery 54 Negative Symptoms 54 μmol L 54 pleiotropic effects 54 glutamate glutamine 54 SGPT 54 methyltransferase 54 allele frequencies 54 eigenvalue 54 serum IGF 54 Hematopoietic 54 Charlson Comorbidity Index 54 subscale scores 54 neuroregenerative 54 Multivariate analysis 54 alanine aminotransferase ALT 54 VEGFR1 54 nicardipine 54 cystatin 54 Mol Cell 54 waist circumference WC 54 Logistic Regression 54 angiographically 53 Lumbar spine 53 apo B 53 quantitative computed tomography 53 chronicity 53 Rating Scale MADRS 53 alexithymia 53 Crohn Disease Activity 53 State Examination MMSE 53 PSA kinetics 53 postoperative complication 53 anthropometric measures 53 Beta Amyloid 53 Patellofemoral 53 renal cysts 53 aMCI 53 polygenic 53 PsA 53 unmeasured confounders 53 p# MAPK 53 distensibility 53 #OHD 53 affective psychosis 53 CYP #D# 53 CYP#A# CYP#D# 53 percutaneous vertebroplasty 53 Non inferiority 53 cardiac perfusion 53 plasma lipids 53 multivariate adjustment 53 T2DM 53 Mantel Haenszel 53 laterality 53 acetabular fractures 53 circulating endothelial cells 53 glucose homeostasis 53 colorectal adenoma 53 intima media thickness 53 transvaginal sonography 53 vasopressor 53 platelet reactivity 53 Novel Compound 53 Spinal Manipulation 53 progesterone receptor PR 53 baseline FEV 53 CFQ R 53 dosimetric 53 postprandial glycemia 53 bladder carcinoma 53 univariate analyzes 53 D dimer 53 collagen degradation 53 osmolality 53 Cronbach alpha 53 HER2 overexpression 53 Antigen Specific 53 multivariate regression 53 androgen depletion 53 DIGE 53 apo AI 53 R#W [002] 53 plasma pharmacokinetics 53 hepatic fibrosis 53 Probabilistic 53 p = NS 53 S. pombe 53 stepwise logistic regression 53 BMI z 53 Autoantibodies 53 elevated IOP 53 left ventricular systolic 53 lipoprotein Lp 53 CI -#.# 53 serum leptin 53 MSH2 53 mitral stenosis 53 Serum creatinine 53 lymphocyte count 53 extrapyramidal symptoms 53 deoxy 53 Neurol 53 spirometric 53 PGC 1α 53 intraclass correlation coefficients 53 estimated GFR 53 metaplasia 53 atherosclerotic renal artery stenosis 53 Mg Usa 53 Int J Radiat Oncol 53 immunodominant 53 Modulates 53 Hb A1C 53 Multivariable 53 T1a 53 FISH fluorescence 53 corneal thickness 53 microvessel density 53 glycated hemoglobin HbA1c 53 BEXXAR Therapeutic Regimen 53 J Am Soc 53 mononuclear 53 lupus anticoagulant 53 Proteinuria 53 serum biomarkers 53 perioperative morbidity 53 stimulated insulin secretion 53 Insulin Glargine 53 hemodynamic variables 53 Androgen 53 alkaline phosphatase ALP 53 HRQL 53 TC HDL 53 ß = 53 nondiabetics 53 QTc prolongation 53 Hypotension 53 serum glucose 53 morphometric vertebral fractures 53 varus deformity 53 histopathological 53 urinary N telopeptide 53 International Prostate Symptom 53 subclinical atherosclerosis 53 bronchopulmonary dysplasia BPD 53 Global Impression CGI 53 immunoreactive 53 IPAH 53 Kaplan Meier curve 53 glycated hemoglobin 53 pharmacodynamic PD 53 intraclass correlation coefficient 53 Insulin sensitivity 53 TIMP 53 Scale CNS 53 progression TTP 53 umbilical artery 53 Score IPSS 53 plasma leptin 53 QIDS SR 53 endometrial thickness 53 genotypic 53 Eur J Endocrinol 53 Ejection fraction 53 bFGF 53 posttreatment 53 primidone 53 glomerular 53 serum homocysteine 53 Apolipoprotein B 53 Bioequivalence 53 troponin T 53 Glycemic load 53 Complications Trial 53 advanced adenoma 53 FOR AN OPEN 53 Prognostic Factors 53 Randomized Evaluation 53 Infarct 53 J Consult Clin 53 Extracellular Matrix 53 Functional Assessment 53 preintervention 53 serum cortisol 53 linear regression analyzes 53 Endothelial Function 53 hypercalciuria 53 hypericin 53 allelic 53 Diabetic Neuropathy 53 = -#.# 53 TPMT 53 glutamic acid decarboxylase 53 lymphocytosis 53 micrometastasis 53 diffusion tensor 53 diabetes mellitus DM 53 Vertebral 53 KDOQI 53 Radiation Induced 53 Daptomycin 53 interleukin IL -6 53 T1 weighted images 53 biopsy Gleason 53 dose proportionality 53 bronchoalveolar lavage BAL 53 Fracture Risk 53 aminotransferases 53 Hypertrophy 53 Polymorphism 53 extrapyramidal side 53 myocardial fibrosis 53 Demonstrate Significant 52 overt nephropathy 52 postoperative chemotherapy 52 histological subtype 52 viral kinetics 52 predictive validity 52 echocardiographic 52 hypothalamic pituitary 52 PANSS scores 52 myocardial infarct size 52 Cronbach 52 pretest probability 52 elevated ALT 52 ventricular myocardium 52 RRM1 52 CLINICAL PHARMACOLOGY 52 achieved statistical significance 52 pT3 52 Patency 52 surrogate markers 52 Prostate Cancer Progression 52 Protein Kinase C 52 endocannabinoid signaling 52 Prolongs Survival 52 #F fluorodeoxyglucose 52 PSA nadir 52 prospective multicentre 52 Fig. 3b 52 biochemical recurrence 52 microvessel 52 LVNC 52 nonpharmacologic 52 Neuropsychiatric Inventory 52 Plasma concentrations 52 clinicopathological features 52 Hemodynamic 52 Clinical Relevance 52 mediated inhibition 52 Renal Disease 52 Hennekens CH 52 baseline serum creatinine 52 Blood Pressure Lowering 52 Heterogeneity 52 Renal Artery 52 RT qPCR 52 Predictive Value 52 acetabular dysplasia 52 prostaglandin E 52 Wechsler Adult 52 carotid intima media 52 F FDG PET 52 myeloperoxidase 52 urinary calcium 52 multivariable logistic regression 52 Trandolapril 52 Kidney Function 52 immunoreactivity 52 Geriatric Depression 52 mU liter 52 Follicular Lymphoma 52 Mol Med 52 Bioheart MyoCell 52 somatostatin receptor 52 enzyme immunoassay EIA 52 Haplotype 52 subcellular localization 52 prespecified 52 C telopeptide 52 ALT elevations 52 serum albumin 52 squared ID2 52 cardiac allograft vasculopathy 52 Metastatic Renal Cell Carcinoma 52 Aurora Kinase 52 Bice WS Jurkovic I. 52 postoperative pulmonary 52 plasma renin activity 52 central corneal thickness 52 YMRS 52 Rheumatol 52 genotypic resistance 52 macrovascular disease 52 cytochrome oxidase 52 IKDC 52 inotropic agents 52 calculi 52 lymphadenectomy 52 microsatellite instability 52 Cytochrome 52 lipoprotein levels 52 gastric adenocarcinoma 52 neurocognitive function 52 inferential statistics 52 creatine kinase 52 beta3 52 adrenoceptor 52 aortic insufficiency 52 p = #.# [003] 52 epoetin alpha 52 Intra articular 52 Neuropsychological 52 radical prostatectomy RP 52 NIHSS 52 Visual acuity 52 intracranial atherosclerosis 52 rCBF 52 NTx 52 BODE index 52 Cyclin E 52 statistically significant p = 52 Quantification 52 familial aggregation 52 immunotoxicity 52 poststroke 52 CYP#A# substrate 52 Mendelian randomization 52 scintigraphic 52 invariance 52 GSTP1 52 attain statistical significance 52 #:#-# [020] 52 Shows Statistically Significant 52 serum aminotransferase levels 52 mRS 52 vertebrobasilar 52 Lesion 52 WOMAC pain 52 Akt activation 52 lymphovascular invasion 52 1alpha 52 carotid IMT 52 hematological relapse 52 HDL LDL 52 Known hypersensitivity 52 proteoglycan 52 Human Leukocyte Antigen 52 Unfractionated Heparin 52 Lower Limb 52 Immunohistochemical 52 gadolinium enhancing lesions 52 Rating Scale UPDRS 52 Sentinel Lymph Node 52 chromosome #p# [002] 52 KOOS 52 = #.#-#.# 52 ECLS 52 bivalirudin monotherapy 52 fluorimetry 52 Ischaemic 52 androgen suppression 52 Dilated Cardiomyopathy 52 mg BID dose 52 Electroencephalography 52 Key secondary endpoints 52 intima media thickness IMT 52 periprocedural MI 52 aspartate aminotransferase 52 hydroxyproline 52 Renal Function 52 cortical atrophy 52 antiangiogenic therapy 52 ω 52 RFLP 52 #.#/#.# mmHg [001] 52 RE LY 52 hypoperfusion 52 preoperatively 52 hyperoxaluria 52 correlation coefficients 52 preterm neonates 52 rs# [001] 52 Radical prostatectomy 52 HADS 52 ^ Tc 52 perfusion imaging 52 postoperative delirium 52 Albuminuria 52 Outpatient Setting 52 DLQI 52 Rate ORR 52 artery stenosis 52 β blockers 52 denervation 52 CD# expression [001] 52 5 HTTLPR 52 antioxidant supplementation 52 mg XP# 52 Inhibitory 52 cranial irradiation 52 CYP#C# genotype 52 Uterine 52 skewness 52 QTc intervals 52 Microdosing 52 aortic regurgitation 52 adrenocorticotropic hormone 52 HMG CoA reductase inhibitor 52 Polymorphisms 52 estimated glomerular filtration 52 C Reactive Protein 52 Histopathological 52 Visual Analog 52 glutamatergic 52 Depressive Symptoms 52 Kalantar Zadeh 52 Black Litterman 52 Arch Neurol 52 SGOT 52 CYP#D# genotype 52 oncologic outcomes 52 thymidine 52 catechol O methyltransferase 52 hepatocellular carcinomas 52 Parkinson Disease PD 52 rho = 52 bivariate analysis 52 graft occlusion 52 nadolol 52 Hazard Ratio HR 52 induced phosphorylation 52 untreated psychosis 52 Microstructure 52 linkage disequilibrium 52 rearfoot 52 HBeAg seroconversion 52 Adiposity 52 glycosylated hemoglobin 52 Pelvic Organ Prolapse 52 transaminase elevations 52 MS DRG 52 Radiographic 52 transaminase 52 colorectal adenocarcinoma 52 Western blotting 52 OGTT 52 calculated creatinine clearance 52 creatinine clearance CrCl 52 hepatic enzyme 52 Left Ventricular Dysfunction 52 Angiographic 52 multivariable 52 glycolytic 52 Apc 52 radical nephrectomy 52 retest reliability 52 #.#/#.# mm Hg [003] 52 Systolic Blood Pressure 52 glycemia 52 Genetic Marker 52 intrathoracic 51 3rd edn 51 peptide receptor 51 IgG antibody 51 carotid plaque 51 metabolic parameters 51 MSCT 51 Doppler echocardiography 51 treat NNT 51 CSF biomarkers 51 hyperalgesia 51 Tubulin 51 Inflammatory Pain 51 peginterferon alpha 51 5-fluorouracil/leucovorin 51 Fulvestrant 51 dorsal root ganglion 51 RECIST Response Evaluation Criteria 51 hip resurfacing arthroplasty 51 Functional Outcomes 51 Papillary 51 intracerebral 51 serum sodium 51 HBeAg 51 Demonstrated Significant 51 meta regression 51 Cardiac Function 51 HIF 1a 51 Septic Shock 51 HIV tropism 51 cortical activation 51 proximal femur 51 SLNB 51 Patients Receiving 51 urothelial carcinoma 51 methodologic 51 Distress Scale 51 FDG PET scans 51 glycated hemoglobin levels 51 parameter estimation 51 Dehydrogenase 51 Non Alcoholic Steatohepatitis 51 transgene expression 51 IFN γ 51 macroscopically 51 natriuresis 51 Ki# 51 MYBPC3 51 troponins 51 lesional 51 linearized 51 glycosylated hemoglobin HbA1c 51 Disord 51 urine cytology 51 serum phosphorus 51 osteopenic 51 mutated K ras 51 J Antimicrob Chemother 51 morphometry 51 Vasc 51 Coronary Artery Calcium 51 Deficient Mice 51 lispro 51 Preoperative 51 unmeasured confounding 51 Preoperatively 51 Antitumor 51 silico prediction 51 J Foot Ankle 51 Abnormal Involuntary Movement 51 ImmuKnow 51 antiphospholipid antibodies 51 adenoma recurrence 51 hyperhomocysteinemia 51 pancreatic adenocarcinoma 51 dopaminergic neuron 51 -#.# ± [001] 51 CHADS 51 explanatory variables 51 Peginterferon Alfa 2a 51 generalized linear 51 Subgroup analyzes 51 Kaplan Meier curves 51 β1 51 LPS induced 51 abacavir Ziagen 51 diabetes dyslipidemia 51 postoperative mortality 51 Physiologic 51 Cytotoxic 51 mammographic density 51 Y BOCS 51 Anthropometric 51 nonischemic 51 HbA1C levels 51 variance ANOVA 51 myocardial dysfunction 51 Clinician Administered PTSD 51 Ejection Fraction 51 prognostic indicators 51 ovarian carcinoma 51 D aspartate NMDA receptor 51 comorbid conditions 51 sodium nitroprusside 51 Ranolazine 51 Arch Intern Med 51 prognostic indicator 51 pleiotropy 51 Intracranial 51 autonomic dysfunction 51 urate oxidase 51 homozygote 51 thromboembolic complications 51 microalbuminuria 51 kappa = 51 thyrotropin 51 % CI #.#-#.# [005] 51 Comorbidity 51 serum bilirubin 51 hemoglobin A1c levels 51 Fibromyalgia Impact Questionnaire 51 CCyR 51 contrast induced nephropathy 51 neurologic progression 51 σ 51 intravascular ultrasonography 51 bronchial reactivity 51 CD# expression [002] 51 hormone receptor status 51 IBDQ 51 Monte Carlo Simulation 51 spectrophotometric 51 sociodemographic characteristics 51 candidate alferminogene tadenovec 51 dopamine D2